블로그
- 모더나 Moderna Stock Surges 177% on Personalized Cancer Vaccine world’s first messenger RNA (mRNA) vaccines, has made a spectacular comeback after years of poor performance This resurgence follows the success of a personalized cancer vaccine co-developed with Merck in late-stage
- 분류 모델 평가 - Confusion Matrix, ROC Curve . - For detecting rare cases such as cancer patients (1% prevalence): Recall works best because missing a cancer patient (FN) is critical.